Chinese Medicine Shensongyangxin Is Effective for Patients with Bradycardia: Results of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

To evaluate the efficacy and safety of Shensong Yangxin (SSYX) in patients with bradycardia arrhythmias, a randomized, double-blind, and placebo-controlled study was conducted. Patients with bradycardia were randomly assigned to receive either SSYX (trial group, n = 115) or placebo (control group, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yunfang, Li, Ning, Jia, Zhenhua, Lu, Feng, Pu, Jielin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914313/
https://www.ncbi.nlm.nih.gov/pubmed/24527049
http://dx.doi.org/10.1155/2014/605714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914313/
https://www.ncbi.nlm.nih.gov/pubmed/24527049
http://dx.doi.org/10.1155/2014/605714

Ejemplares similares